Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.

[1]  A. Rangaswami,et al.  Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry , 2022, Cancer.

[2]  A. Heinzel,et al.  The effect of surveillance for differentiated thyroid carcinoma in childhood cancer survivors on survival rates: a decision-tree-based analysis , 2022, Endocrine connections.

[3]  David B. Wilson,et al.  Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/DICER1 Registry , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Merchant,et al.  Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321) , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  I. Yeh,et al.  Spitz melanocytic tumours – a review , 2021, Histopathology.

[6]  C. Weldon,et al.  Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  P. Vlcek,et al.  RET, NTRK, ALK, BRAF and MET fusions in a large cohort of pediatric papillary thyroid carcinomas. , 2020, Thyroid : official journal of the American Thyroid Association.

[8]  M. Fassnacht,et al.  Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib. , 2020, The Journal of clinical endocrinology and metabolism.

[9]  M. Berger,et al.  PD-1 Blockade in Advanced Adrenocortical Carcinoma. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  A. Pappo,et al.  Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. O'Brien,et al.  Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Z. J. Qian,et al.  Pediatric Thyroid Cancer Incidence and Mortality Trends in the United States, 1973-2013. , 2019, JAMA otolaryngology-- head & neck surgery.

[13]  Jessica L. Davis,et al.  Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. , 2018, The Lancet. Oncology.

[14]  Gretchen M. Williams,et al.  DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies , 2018, Clinical Cancer Research.

[15]  M A Weinstock,et al.  Epidemiology of melanoma. , 2017, Cancer treatment and research.

[16]  W. Foulkes,et al.  Retinoblastoma and Neuroblastoma Predisposition and Surveillance , 2017, Clinical Cancer Research.

[17]  L. Strong,et al.  Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome , 2017, Clinical Cancer Research.

[18]  E. Beierle,et al.  Colorectal carcinoma in pediatric patients: A comparison with adult tumors, treatment and outcomes from the National Cancer Database. , 2016, Journal of pediatric surgery.

[19]  F. Mottaghy,et al.  Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents – Recommendations of the GPOH-NPC Study Group , 2016, Klinische Pädiatrie.

[20]  K. Harms,et al.  Atypical Spitz Tumors: A Diagnostic Challenge. , 2015, Archives of pathology & laboratory medicine.

[21]  M. Luster,et al.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. , 2015, Thyroid : official journal of the American Thyroid Association.

[22]  Claudia Eichler-Jonsson,et al.  Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Cormier,et al.  Melanoma incidence rises for children and adolescents: an epidemiologic review of pediatric melanoma in the United States. , 2013, Journal of pediatric surgery.

[24]  I. Zalaudek,et al.  Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview. , 2013, Dermatologia clinica.

[25]  Jenine K. Harris,et al.  Incidence of Childhood and Adolescent Melanoma in the United States: 1973–2009 , 2013, Pediatrics.

[26]  H. Christiansen,et al.  Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults , 2012, Cancer.

[27]  A. Pappo,et al.  Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Ross,et al.  Trends in childhood cancer incidence in the U.S. (1992–2004) , 2008, Cancer.

[29]  C. Rodríguez-Galindo,et al.  Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D. Evans,et al.  Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors. , 1999, American journal of human genetics.

[31]  C. Portwine,et al.  High frequency of germline p53 mutations in childhood adrenocortical cancer. , 1994, Journal of the National Cancer Institute.

[32]  R. Lloyd,et al.  Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia. A study of a Brazilian population. Brazilian Group for Treatment of Childhood Adrenocortical Tumors. , 1994, American journal of clinical pathology.

[33]  M. Wooten,et al.  Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature , 1993, Cancer.